Skip to main content

InspireMD, Inc.

NSPR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001433607

No open-market purchases or sales by InspireMD, Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $15.1M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding InspireMD, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of NSPR: Q2 2025 compared with Q3 2025
MeasureQ2 2025Q3 2025Change
Holders3641+5
Shares14.1M22.7M+8.67M (+61.6%)
Value$31.9M$54.8M+$22.9M (+71.6%)

New holders (10)

Institutions that held InspireMD, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to NSPR in Q3 2025
InstitutionSharesValue% of portfolio
Standard Life Aberdeen plc2,481,117$5.98M0.01%
Ghisallo Capital Management LLC921,587$2.22M0.07%
Ingalls & Snyder LLC225,002$542.0K0.02%
Commonwealth Equity Services, LLC32,550$78.0K0.00%
Uniting Wealth Partners, LLC21,066$50.8K0.01%
Pallas Capital Advisors LLC11,000$26.5K0.00%
Group One Trading, L.P.4,000$9.64K0.00%
Bank of America Corp608$1.47K0.00%
Simplex Trading, LLC462$1.00K0.00%
Koesten, Hirschmann & Crabtree, INC.2$50.00%

Sold out (5)

Institutions that held InspireMD, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of NSPR in Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
UBS Group AG124,638$282.9K
Raymond James Financial Inc44,604$101.3K
JPMorgan Chase & Co2,853$6.48K
Royal Bank of Canada1,167$3.00K
National Bank of Canada206$468